A Study to Evaluate Rocatinlimab (AMG 451) in Healthy Chinese Participants

Conditions: Atopic Dermatitis Interventions: Drug: Rocatinlimab Sponsors: Amgen Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials